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Applicability to Clinical Practice
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Statement of the Problem
References
• Atherosclerotic cardiovascular disease (ASCVD) is highly 
prevalent in today’s society and contributes to high rates of 
mortality involved with heart disease. 
• The initial assessment of ASCVD and risk stratification 
concerning the development of an acute coronary event can 
be performed in a number of ways.  
• Current American Heart Association (AHA) guidelines 
recommend exercise stress testing (ETT) as the initial, 
noninvasive evaluation of choice. 
• However, the accuracy of this test is highly dependent on 
the patient’s endurance, body mass index, and artifact, 
making analyzation difficult.  
• Non-contrast cardiac computed tomography (CT) with 
coronary artery calcium (CAC) scoring has been shown to 
be specific and sensitive, however only recommended for 
further evaluation post ETT, those with insignificant stress 
test findings, and those unable to exercise. 
• The purpose of this study is to determine if CAC scoring is a 
more useful predictor of ASCVD and acute coronary events 
compared to exercise stress testing. 
• The review of literature compares accuracy, predictability, 
and cost of ETT versus CAC scoring. 
• The results display high sensitivity using CAC as the initial 
diagnostic test in patients determined as low to intermediate 
risk for an acute coronary event without significant increase 
in cost. 
• The findings may be used to justify current guidelines or 
propose alterations to certain patient populations as to 
which test would be more accurate and cost-effective in the 
risk stratification of ASCVD.
• Many of today’s advancements in medical technology 
have shown to be more accurate and efficient, but also 
more costly. 
• Studies evaluating the sensitivity and cost-effectiveness 
comparing ETT and CAC scoring are needed to negate 
which method of evaluation would be most beneficial 
assessing risk stratification of an acute coronary event.
• In patients with symptoms of ASCVD, is CAC scoring a more 
useful or accurate predictor of ASCVD and acute coronary 
events than exercise stress electrocardiogram?
• In diagnosing ASCVD and assessing risk stratification, is 
exercise stress electrocardiogram or CAC scoring more cost 
effective as an initial screening test?
• The review of literature focuses on the assessment of adult 
patients with the indication for ETT or CAC scoring for risk 
stratification and diagnosis of ASCVD.  Full articles were 
acquired from the following electronic medical databases: 
PubMed, The Cochrane Library, CINAHL and Clinical Key 
with preference given to meta-analysis, systematic reviews, 
and cross-sectional studies. 
• Current NICE guidelines recommend CAC scoring to assess 
some low-risk chest pain patients, stress imaging for 
medium-risk, and immediate cardiac catheterization for high-
risk. AHA/ACC guidelines suggest ETT for patients 
considered low to intermediate risk. High risk, specific 
populations should automatically undergo imaging studies.
The review of literature revealed the following main points:
• Amsterdam et al (2010) demonstrated a sensitivity and 
specificity of ETT of 70% and 75% respectively and found 
high sensitivity (100% negative predictive value) with a CAC 
score of 0.
• Greenland et al (2007) found that a CAC >0 increases a 
patient’s risk of a coronary event by 4-fold (p<.0001) and 
higher levels of CAC correlated with higher rates of coronary 
events.
• McClelland et al (2015) concluded the addition of CAC score 
to the MESA risk score provided significant improvements in 
risk prediction of ASCVD (C-statistic 0.80 vs. 0.75; 
p<0.0001) and found the combination of CAC and MESA 
risk score in predicting 10-year risk within one-half of 
percent of the actual observed rate.
• Bengrid et al (2013) determined the sensitivity of ETT was 
lower than CAC (p<0.001) at all stenosis levels, but higher 
specificity than CAC ≥0-400.
• A study by Purvis et al (2011) concluded the strategy 
implemented by 2010 NICE results with a sensitivity of 88% 
and a NPV of 98% for excluding obstructive coronary 
disease.
• Rozanski et al (2011) determined a decrease in downstream 
testing and medication cost by 37% and 25% with CAC=0.
• Demir et al (2015) found patients evaluated using ETT 
compared to those evaluated via cardiac imaging following 
NICE guidelines to have significantly higher cost (p<0.0001) 
due to overall higher cost, lesser efficacy, and higher rate of 
invasive coronary angiography.
• Kelly et al (2011) found opposing results displaying an 
average increase of $8300 per 100 patients using NICE 
guidelines.
• Ramen et al (2012)) concluded CAC to be a cost-effective 
strategy for initial investigation if the prior probability of 
ASCVD is <30%.
• With recent CDC statistics displaying heart disease as the 
leading cause of death in the United States, accurate diagnosis 
and risk stratification of ASCVD is easily justifiable to allow the 
incorporation of adequate treatment to reduce mortality, 
morbidity, and healthcare cost related to heart disease.
• The purpose of this study is to determine if CAC scoring is a 
more useful predictor of ASCVD and acute coronary events 
compared to ETT considering cost, efficacy and accuracy. The 
method of evaluation is performed via literature review 
evaluating current guidelines, systematic reviews, and cross-
sectional studies published within the last ten years pertaining 
strictly to adult individuals. 
• The results confirmed that both CAC scoring and ETT are effective tools in triaging and evaluating patients with symptoms 
of ASCVD. The two measurements provide fundamentally different diagnostic information. CAC scoring offers information 
concerning anatomical defects by assessing calcium in coronary arteries while ETT assesses cardiac function by detecting 
ischemia during myocardial exertion. 
• The data collected demonstrated similarities among effectiveness of studies but also conflicting results. The most recent 
guidelines and studies based in the UK tend to favor the use of CAC scoring over ETT in patients with low to moderate risk 
for coronary events contributing to the evident difference in recommendations published most recently by the AHA and 
NICE.
The literature reviewed can offer modifications to current clinical 
practice guidelines in the assessment of stable angina and risk 
stratification of ASCVD by considering the following steps:
1. Identify high-risk conditions requiring emergent invasive 
intervention.
2. Identify major risk factors and estimate 10-year likelihood for 
developing a coronary event.
3. ETT is recommended by current ACC/AHA guidelines for initial 
evaluation, but evidence demonstrated CAC scoring as an 
appropriate substitute in patients considered in the low to 
intermediate risk category, those with endurance unprovoked 
by exercise, and those with contraindications to ETT.
4. Consider CAC score to amplify clinical judgement in risk 
stratification and to initiate treatment as indicated.
• CAC=0 consider other causes of chest pain
• CAC 1-400 medication management/consider risk and 
further assessment with coronary angiography




• High Sensitivity (97%) with nearly 100% NPV
• Lower rate of downstream testing and medication cost
• Prognostic value with degree of CAC
• Ability to detect other causes of angina (valve 
calcification, effusion, thickening)
• Few contraindications (pregnancy, weight limits)
• Assess anatomical defects
• Lower Specificity (26%)
• Radiation exposure (1mSv)
• Higher cost
• Less accessibility
• May be unnecessary when hard evidence (elevated LDL, low 
HDL, history) is noted and will not alter treatment or 
compliance
ETT




• Assess functional capacity
• Low Sensitivity (38.9%)
• High false positive rate (common in females, diabetics, and 
LBBB)
• Results are operator dependent
• Results are limited and dependent upon exercise tolerance, 
disability, medications, previous EKG changes
• Many contraindications: acute MI within 2 days, unstable 
angina, hemodynamic compromise, uncontrolled arrhythmia, 
endocarditis, symptomatic aortic stenosis, decompensated 
heart failure, disability
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